Diversion of Buprenorphine/Naloxone Coformulated Tablets in a Region with High Prescribing Prevalence

REFERENCES

• http://buprenorphine.samhsa.gov/fulllaw.html
   Google Scholar
• Ling , W and Smith , D . 2002 . Buprenorphine: blending practice and research . J Subst Abuse Treat , 23 : 87 – 92 .
   PubMed Web of Science ®Google Scholar
• Fielin , D and O'Connor , P . 2002 . Office-based treatment of opioid-dependent patients . NEJM , 347 : 817 – 23 .
   PubMedGoogle Scholar
• Walsh , S , Preston , K , Stitzer , M , Cone , E J and Bigelow , G E . 1994 . Clinical pharmacology of buprenorphine: ceiling effects at high doses . Clin Pharmacol Ther , 55 : 569 – 80 .
   PubMed Web of Science ®Google Scholar
• Liguori , A , Morse , W and Bergman , J . 1996 . Respiratory effects of opioid full and partial agonists in rhesus monkeys . J Pharmacol Exp Ther , 277 : 462 – 72 .
   PubMed Web of Science ®Google Scholar
• Petry , N , Bickel , W and Badger , G . 2001 . Examining the limits of the buprenorphine interdosing interval; daily, every-third-day and every-fifth-day dosing regimens . Addiction , 96 : 823 – 34 .
   PubMed Web of Science ®Google Scholar
• Johnson , R , Eissenberg , T , Stitzer , M , Strain , E C , Liebson , I A and Bigelow , G E . 1995 . Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing . Drug Alcohol Depend , 40 : 27 – 35 .
   PubMed Web of Science ®Google Scholar
• Fudala , P , Jaffe , J H , Dax , E M and Johnson , R E . 1990 . Use of buprenorphine in the treatment of opioid addiction. II. physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal . Clin Pharmacol Ther , 47 : 525 – 34 .
   PubMed Web of Science ®Google Scholar
• Megarbane , B , Hreiche , R , Pirnay , S , Marie , N and Baud , F . 2006 . Does high-dose burenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences . Toxicol Rev , 25 : 79 – 85 .
   PubMedGoogle Scholar
• Lufty , K and Cowan , A . 2004 . Buprenorphine: a unique drug with complex pharmacology . Curr Neuropharmacol , 2 : 395 – 402 .
   PubMedGoogle Scholar
• Smith , M , Bailey , J , Woody , G and Kleber , H . 2007 . Abuse of buprenorphine in the United States: 2003–2005 . J Addict Dis , 26 : 107 – 11 .
   PubMed Web of Science ®Google Scholar
• Wilford , B B and Maxwell , J C . 2006 . “ Diversion and abuse of buprenorphine: a brief assessment of emerging indicators ” . In Division of pharmacologic therapies , 1 – 70 . Washington, DC : US Department of Health & Human Services . SAMHSA, ed.
   Google Scholar
• Alho , H , Sinclair , D , Vuori , E and Holopainen , A . 2007 . Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users . Drug Alcohol Depend , 88 : 75 – 8 .
   PubMed Web of Science ®Google Scholar
• Stimmel , B . 2007 . Buprenorphine misuse, abuse, and diversion: when will we ever learn? . J Addict Dis , 26 : 1 – 3 .
   PubMed Web of Science ®Google Scholar
• 2008 . Results from the 2007 national survey on drug use and health: national findings , Washington, DC : US Department of Health & Human Services . SAMHSA, ed.
   Google Scholar
• Cicero , T , Inciardi , J and Munoz , A . 2005 . Trends in abuse of oxycontin and other opioid analgesics in the united states: 2002–2004 . J Pain , 6 : 662 – 72 .
   PubMed Web of Science ®Google Scholar
• Donovan , D . 2008 . Mixed progress for bupe . The Baltimore Sun , Jul 12
   Google Scholar
• Schulte , F , Donovan , D and Niedowski , E . 2007 . The buprenorphine experiment . The Baltimore Sun , Dec 16, 2007
   Google Scholar
• Roux , P , Carrieri , M , Villes , V , Dellamonica , P , Poizot-Martin , I , Ravaux , I and Spire , B . 2008 . The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study . Addiction , 103 ( 11 ) : 1828 – 36 .
   PubMed Web of Science ®Google Scholar
• Sullivan , L , Moore , B , Chawarski , M , Pantalon , M V , Barry , D , O'Connor , P G , Schottenfeld , R S and Fiellin , D A . 2008 . Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors . J Subst Abuse Treat , 35 : 87 – 92 .
   PubMed Web of Science ®Google Scholar
• Spire , B , Lucas , G and Carrieri , M . 2007 . Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST) . Int J Drug Policy , 18 : 262 – 70 .
   PubMed Web of Science ®Google Scholar
• Maher , L , Jalaludin , B , Wand , H , Jayasuriya , R , Dixon , D and Kaldor , J . 2007 . Impact of reduction in heroin availability on patters of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in new south wales, australia . Drug Alcohol Depend , 89 : 244 – 50 .
   PubMedGoogle Scholar
• Todd , C , Abed , A , Strathdee , S , Scott , P T , Botros , B A , Safi , N and Earhart , K C . 2007 . HIV, hepatitis C, and hepatitis B infections and associated risk behaviour in injection drug users, kabul, afghanistan . Emerg Infect Dis , 13 : 1327 – 31 .
   PubMed Web of Science ®Google Scholar
• Wines , J , Saitz , R , Horton , N , Lloyd-Travaglini , C and Samet , J . 2006 . Overdose after detoxification: a prospective study . Drug Alcohol Depend , 89 : 161 – 9 .
   Google Scholar
• Bailey , J , Campagna , E and Dart , R . 2008 . The underrecognized toll of prescription opioid abuse in young children . Ann Emerg Med , 53 ( 4 ) : 419 – 24 .
   PubMedGoogle Scholar
• Geib , A , Babu , K , Ewald , M and Boyer , E . 2006 . Adverse effects in children after unintentional buprenorphine exposure . Pediatrics , 118 : 1746 – 51 .
   PubMed Web of Science ®Google Scholar
• Gonzalez , G , Oliverto , A and Kosten , T . 2004 . Combating opiate dependence: a comparison among the available pharmacologic options . Expert Opin Pharmacother , 5 : 713 – 25 .
   PubMed Web of Science ®Google Scholar
• Wunsch , M , Cropsey , K , Campbell , E and Knisely , J . 2008 . Oxycontin use and misuse in three populations: substance abuse patients, pain patients, and criminal justice participants . J Opioid Manag , 4 : 73 – 9 .
   PubMedGoogle Scholar